150 related articles for article (PubMed ID: 3548121)
1. [Phenotypic and genotypic marker in malignant lymphomas: cellular origin of Hodgkin's disease and malignant histiocytosis as well as implications for classifying T-cell and B-cell lymphomas].
Stein H; Gerdes J
Verh Dtsch Ges Pathol; 1986; 70():127-51. PubMed ID: 3548121
[No Abstract] [Full Text] [Related]
2. Enteropathy-associated T cell lymphoma (malignant histiocytosis of the intestine) is recognized by a monoclonal antibody (HML-1) that defines a membrane molecule on human mucosal lymphocytes.
Spencer J; Cerf-Bensussan N; Jarry A; Brousse N; Guy-Grand D; Krajewski AS; Isaacson PG
Am J Pathol; 1988 Jul; 132(1):1-5. PubMed ID: 3260750
[TBL] [Abstract][Full Text] [Related]
3. Surface membrane phenotypic expression and treatment response of malignant lymphomas.
Lauder I; Bird CC; Child JA; Grigor I
J Pathol; 1985 Mar; 145(3):259-68. PubMed ID: 3920370
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies against SU-DHL-1 cells stain the neoplastic cells in true histiocytic lymphoma, malignant histiocytosis, and Hodgkin's disease.
Hsu SM; Pescovitz MD; Hsu PL
Blood; 1986 Jul; 68(1):213-9. PubMed ID: 2424524
[TBL] [Abstract][Full Text] [Related]
5. Expression of Tac antigen in B cell lymphomas.
Laurent G; Al Saati T; Olive D; Laurent JC; Poncelet P; Delsol G
Clin Exp Immunol; 1986 Aug; 65(2):354-62. PubMed ID: 3024885
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic expression of non-Hodgkin's lymphomas in China.
Xu LZ; Tu LY; Liu YF; Hsu SM; Qiu BS; Li ZX
J Natl Cancer Inst; 1984 Sep; 73(3):635-8. PubMed ID: 6236322
[TBL] [Abstract][Full Text] [Related]
7. Lymphomas: membrane markers and cell flow cytometric diagnosis.
Glassman AB; Self S; Christopher J
Ann Clin Lab Sci; 1987; 17(1):1-7. PubMed ID: 3579204
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical analysis of human lymphomas with monoclonal antibodies to B cell and Ia antigens reactive in paraffin sections.
Marder RJ; Variakojis D; Silver J; Epstein AL
Lab Invest; 1985 May; 52(5):497-504. PubMed ID: 3887032
[TBL] [Abstract][Full Text] [Related]
9. How to differentiate between T-cell-rich B-cell lymphoma and lymphocyte-predominant Hodgkin's disease. Evidence for the value of MB1 and 4KB5 immunostaining.
Schmidt U; Herbst J; Metz KA; Leder LD
J Pathol; 1996 Jun; 179(2):138-44. PubMed ID: 8758204
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical staining of non-Hodgkin's lymphoma in paraffin sections using the MB1 and MT1 monoclonal antibodies.
Dobson CM; Myskow MW; Krajewski AS; Carpenter FH; Horne CH
J Pathol; 1987 Nov; 153(3):203-12. PubMed ID: 3323430
[TBL] [Abstract][Full Text] [Related]
11. [T-cell lymphoma].
Hurwitz N; Vorst EJ; Evron R; Reichman N; Reznitsky P; Bassous L; Berrebi A
Harefuah; 1990 Feb; 118(3):146-8. PubMed ID: 2341065
[TBL] [Abstract][Full Text] [Related]
12. Malignant histiocytosis in infants: surface marker analysis of malignant cells in two cases.
Ishii E; Hara T; Okamura J; Suda M; Takeuchi T; Iida K; Ueda K
Med Pediatr Oncol; 1987; 15(2):102-8. PubMed ID: 3495721
[TBL] [Abstract][Full Text] [Related]
13. Practical approach to the immunodiagnosis of lymphomas emphasizing differential diagnosis.
Warnke RA; Weiss LM
Cancer Surv; 1985; 4(2):349-58. PubMed ID: 3879857
[TBL] [Abstract][Full Text] [Related]
14. [Diagnosis and classification of hematologic tumors using anti-lymphocyte monoclonal antibodies].
Kikuchi K
Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):551-8. PubMed ID: 6603817
[TBL] [Abstract][Full Text] [Related]
15. Mouse monoclonal antibodies against the idiotype of human B cell non-Hodgkin lymphomas: production, characterization and use to monitor the progress of disease.
Rankin EM; Hekman A
Eur J Immunol; 1984 Dec; 14(12):1119-26. PubMed ID: 6394351
[TBL] [Abstract][Full Text] [Related]
16. Neuron-specific enolase (gamma enolase, gamma-gamma dimer) expression in Hodgkin's disease and large cell lymphomas.
Massarelli G; Onida GA; Piras MA; Marras V; Mura A; Tanda F
Anticancer Res; 1999; 19(5B):3933-8. PubMed ID: 10628334
[TBL] [Abstract][Full Text] [Related]
17. A practical approach to immunophenotyping of lymphomas. Comparison of immunohistologic and immunocytologic techniques.
Sun T; Susin M
Ann Clin Lab Sci; 1987; 17(1):14-26. PubMed ID: 3555278
[TBL] [Abstract][Full Text] [Related]
18. Leu-M1--a marker for Reed-Sternberg cells in Hodgkin's disease. An immunoperoxidase study of paraffin-embedded tissues.
Pinkus GS; Thomas P; Said JW
Am J Pathol; 1985 May; 119(2):244-52. PubMed ID: 3887932
[TBL] [Abstract][Full Text] [Related]
19. Reactivity of Leu 1 and T101 monoclonal antibodies with B cell lymphomas (correlations with other immunological markers).
Al Saati T; Laurent G; Caveriviere P; Rigal F; Delsol G
Clin Exp Immunol; 1984 Dec; 58(3):631-8. PubMed ID: 6239721
[TBL] [Abstract][Full Text] [Related]
20. Coexpression of epithelial membrane antigen (EMA), Ki-1, and interleukin-2 receptor by anaplastic large cell lymphomas. Diagnostic value in so-called malignant histiocytosis.
Delsol G; Al Saati T; Gatter KC; Gerdes J; Schwarting R; Caveriviere P; Rigal-Huguet F; Robert A; Stein H; Mason DY
Am J Pathol; 1988 Jan; 130(1):59-70. PubMed ID: 2827494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
